Suchergebnisse - "Katsumata, Noriyuki"

PubPharm (384)

1

Interstitial lung disease with prolonged fever that occurred during long-term administration of olaparib in a 74-year-old ovarian cancer patient : Radiological features and considerations for preventing delayed diagnosis

enthalten in: Radiology case reports | 2024

von Saito, Y. | Yamaguchi, R. | Suzuki, T. | +7

2

Single-Exon Deletions of ZNRF3 Exon 2 Cause Congenital Adrenal Hypoplasia

enthalten in: The Journal of clinical endocrinology and metabolism | 2024

von Amano, N. | Narumi, S. | Aizu, K. | +6

3

Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain : a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2023

von Shinkai, M. | Katsumata, N. | Kawai, S. | +18

4

Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator

enthalten in: Supportive care in cancer | 2023

von Shinkai, M. | Katsumata, N. | Kawai, S. | +18

5

Single-exon deletions ofZNRF3exon 2 cause congenital adrenal hypoplasia

enthalten in: bioRxiv.org | 2023

von Amano, N. | Narumi, S. | Aizu, K. | +6

6

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer : a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2023

von Mizuno, M. | Ito, K. | Nakai, H. | +18

7

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2022

von Mizuno, M. | Ito, K. | Nakai, H. | +18

8

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2022

von Mizuno, M. | Ito, K. | Nakai, H. | +18

9

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2022

von Mizuno, M. | Ito, K. | Nakai, H. | +18

10

Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab : data from real-world clinical practice

enthalten in: International journal of clinical oncology | 2022

von Sugiyama, T. | Katsumata, N. | Toita, T. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[39]